USPTO serial 97853121
COSTCHECK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 13, 2026
- Examiner
- XU, ELAINE YILIN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COSTCHECK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
ALEXANDRIA, VA, US
Alexandria, VA, US
ALEXANDRIA, VA, US
ALEXANDRIA, VA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gregory B. Phillips
Gregory B. Phillips KNOBBE, MARTENS, OLSON & BEAR LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Electronic data collection, management, analysis, and display services being a form of analysis of market research data through data visualization for business purposes, namely, in the fields of medicine, healthcare, pharmaceuticals, and biotechnology; Business services provided to the medical, healthcare, pharmaceutical, and biotechnology industries, namely, the collection, reporting, and analysis of healthcare and pharmaceutical quality data for business purposes | ACTIVE | — |
| 042 | Data Warehousing; Providing temporary use of non-downloadable computer software for supply chain management of pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for monitoring purchasing trends and pricing for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information regarding cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding cost-effective alternatives and products in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding cost-effective alternative suppliers in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding compliance with contracts, discount programs, and rebates in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records in connection with purchase pricing, budgeting, discounts, and rebates; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records in connection with contract compliance and Group Purchasing Organizations (GPO) compliance; Providing temporary use of non-downloadable computer software for assessing, reviewing and reporting data trends found in prescription and medication records; Providing temporary use of non-downloadable computer software for monitoring, tracking, and taking inventory of pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for use in supply chain management of pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for monitoring purchasing trends and pricing for pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information regarding cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding cost-effective alternatives and products in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding cost-effective alternative suppliers in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Software as a service (SAAS) services featuring software for providing information and recommendations regarding compliance with contracts, discount programs, and rebates in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records in connection with purchase pricing, budgeting, discounts, and rebates; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records in connection with contract compliance and Group Purchasing Organizations (GPO) compliance; Software as a service (SAAS) services featuring software for assessing, reviewing and reporting data trends found in prescription and medication records; Software as a service (SAAS) services featuring software for monitoring, tracking, and taking inventory of pharmaceuticals, vaccines, and medications | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks owned by KitCheck, Inc.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named COSTCHECK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 13, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 21, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 21, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 12, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 30, 2025 | IUAF | USE AMENDMENT FILED | — |
| Dec 30, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 13, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 12, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 12, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 12, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 19, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 19, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 2, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 2, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 2, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 1, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 12, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 17, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 17, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 9, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 14, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 14, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Mar 14, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jan 3, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 14, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 27, 2023 | NWAP | NEW APPLICATION ENTERED | — |